Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE3
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE3
CDDO to Treat Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)
- Status
- COMPLETED
- Phase
- PHASE1
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE3
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
- Status
- UNKNOWN
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
- Status
- TERMINATED
- Phase
- PHASE2